RESEARCH NOTE
·
Impedimed Ltd (IPD)
A health care company breaking 200-week EMA
Special
ASX
This report is available to subscribers
The full research note on Impedimed Ltd — our view, the levels we are working to and the reasoning behind them — is part of a Kapitales subscription.